Amneal Pharmaceuticals (AMRX) Acquisitions (2018 - 2021)

Amneal Pharmaceuticals' Acquisitions history runs 3 years deep, the most recent figure standing at $72.7 million for Q4 2021.

• In Q4 2021, Acquisitions changed N/A year-over-year to $72.7 million; the TTM figure through Dec 2022 stood at $72.7 million (down 50.38% YoY), while the FY2022 annual figure was $84.7 million, down 42.19% from the prior year.
• Acquisitions was $72.7 million for Q4 2021 at Amneal Pharmaceuticals, down from $73.8 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $253.6 million in Q1 2020 to a low of -$2.6 million in Q3 2020.
• Historically, Acquisitions has averaged $66.9 million across 3 years, with a median of $38.0 million in 2018.
• Biggest YoY gain for Acquisitions was 19587.47% in 2021; the steepest drop was 19587.47% in 2021.
• A 3-year view of Acquisitions shows it stood at $3.3 million in 2018, then tumbled by 179.76% to -$2.6 million in 2020, then surged by 2854.36% to $72.7 million in 2021.
• The last three Acquisitions figures came in at $72.7 million (Q4 2021), $73.8 million (Q2 2021), and -$2.6 million (Q3 2020), per Business Quant data.